MINI FUTURE OPTIONSSCHEIN PUT - BIOGEN IDEC | Delayed Deutsche Boerse AG 13:34:58 28/06/2024 BST | ||
| 6.81 EUR | -0.29% |
|
| Current month | -4.48% | ||
| 1 month | -11.18% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
BIOGEN INC.
Latest news about BIOGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 28/06/24 | 6.81 | -0.29% |
| 27/06/24 | 6.83 | -7.20% |
| 26/06/24 | 7.36 | -0.41% |
| 25/06/24 | 7.39 | +4.82% |
| 24/06/24 | 7.05 | -3.95% |
Delayed Quote Deutsche Boerse AG
Last update June 28, 2024 at 01:34 pm
More quotesStatic data
| Product type | Knock-Out with Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | BIOGEN INC. |
| Issuer | DZ BANK |
| WKN | DJ5S1C |
| ISIN | DE000DJ5S1C8 |
| Date issued | 26/10/2023 |
| Strike | 300.5 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 4.46 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 10.46 € |
|---|---|
| Lowest since issue | 2.98 € |
| Spread | 0.06 € |
| Spread % | 0.87% |
Company Profile
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows:
- sales of medicines (73,7%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.;
- royalties (17,2%) ;
- other (9,1%): primarily revenues from partnership agreements.
Sector
-
Consensus: Biogen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
35
Last Close Price
228.7
USD
Average target price
283.2
USD
Spread / Average Target
+23.80%
- Stock Market
- Certificates
- Certificat
